UnknownPhase 2NCT02797626

Trial to Evaluate Progression Free Survival With Primary Retroperitoneal Lymph-node Dissection (pRPLND) Only in Patients With Seminomatous Testicular Germ Cell Tumors With Clinical Stage IIA/B (PRIMETEST)

Studying Germ cell tumor of testis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Heinrich-Heine University, Duesseldorf
Principal Investigator
Peter Albers, M.D., PhD
Department of Urology, Heinrich Heine University, Duesseldorf, Germany
Intervention
Primary retroperitoneal lymph-node dissection (pRPLND)(procedure)
Enrollment
30 enrolled
Eligibility
MALE
Timeline
20162021

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02797626 on ClinicalTrials.gov

Other trials for Germ cell tumor of testis

Additional recruiting or active studies for the same condition.

See all trials for Germ cell tumor of testis

← Back to all trials